Recently, Sinocare said it has agreed to acquire Nipro Diagnostics Inc. a wholly-owned subsidiary of Nipro Corporation, with $272.5 million. According to the acquisition agreement, Nipro Corporation will keep purchasing Nipro Diagnostics’ productions from Sinocare.

Located in Fort lauderdale, Florida, Nipro Diagnostics is a global health company. Nipro Diagnostics has become a leading supplier of co-branded blood glucose monitoring systems to retailers. 2014 Nipro Diagnostics’ revenue was $146 million, ranked sixth in the world.

Through acquired Nipro Diagnostics, Sinocare will expanding its market share rapidly in America.